This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
by Indrajit Bandyopadhyay
OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
OMCLNegative Net Change OPRXNegative Net Change TDOCNegative Net Change
medical medical-devices
PacBio Enters Carrier Screening Market With PureTarget Expansion
by Zacks Equity Research
PACB expands its PureTarget portfolio, streamlining carrier screening with HiFi sequencing to meet rising global demand.
TMOPositive Net Change ILMNPositive Net Change QGENPositive Net Change PACBNegative Net Change
medical medical-devices
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
by Zacks Equity Research
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.
TMOPositive Net Change HOLXNegative Net Change QGENPositive Net Change QDELNegative Net Change
medical medical-devices
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
by Zacks Equity Research
Quest Diagnostics' Haystack Oncology joins Rutgers Cancer Institute to study how its ctDNA MRD test can guide therapy for stage II/III lung cancer.
DGXPositive Net Change QGENPositive Net Change EXASNegative Net Change GHPositive Net Change
medical medical-devices
IDEXX Laboratories Stock Rallies 52.9% YTD: What's Behind the Drive?
by Zacks Equity Research
IDXX soars 52.9% YTD, fueled by strong CAG Diagnostics growth, global expansion and rising demand for software solutions.
BSXPositive Net Change CAHPositive Net Change MASINegative Net Change IDXXNegative Net Change
medical medical-devices
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
by Indrajit Bandyopadhyay
ISRG and ZBH both push robotics forward, but valuation and Zacks Rank tilt near-term upside toward Zimmer Biomet. Which one offers a better bet?
ISRGPositive Net Change ZBHNegative Net Change
medical medical-devices
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis
by Zacks Equity Research
Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.
WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change HTFLNegative Net Change
medical medical-devices
Beat the Market the Zacks Way: Helios Technologies, InterDigital, UnitedHealth in Focus
by Santanu Roy
Helios Technologies, InterDigital and UnitedHealth shine as Zacks' strategies deliver strong gains across model portfolios.
UNHPositive Net Change FASTPositive Net Change MUNegative Net Change TMOPositive Net Change LRCXNegative Net Change ORCLNegative Net Change IDCCNegative Net Change CCOPositive Net Change MTZPositive Net Change NOBLPositive Net Change KNSANegative Net Change HLIONegative Net Change
business-services computers construction industrial-products medical medical-devices semiconductor
Do Options Traders Know Something About Brainsway Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Brainsway stock based on the movements in the options market lately.
BWAYNo Net Change
medical medical-devices
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
by Debanjana Dey
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
HIMSNegative Net Change DOCSNegative Net Change
medical medical-devices
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
by Zacks Equity Research
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
AXGNNegative Net Change INGNNegative Net Change NVSTNegative Net Change GEHCNegative Net Change
medical medical-devices
Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail
by Zacks Equity Research
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
ABTPositive Net Change MASINegative Net Change PAHCPositive Net Change NVSTNegative Net Change
medical medical-devices
Implied Volatility Surging for Aurora Cannabis Stock Options
by Zacks Equity Research
Investors need to pay close attention to ACB stock based on the movements in the options market lately.
ACBPositive Net Change
medical medical-devices
Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally?
by Zacks Equity Research
PODD stock rallies 37.4% in a year, fueled by Omnipod 5 adoption, global launches and expanding reach in diabetes care.
BSXPositive Net Change CAHPositive Net Change MASINegative Net Change PODDNegative Net Change
medical medical-devices
New Strong Buy Stocks for September 26th
by Zacks Equity Research
FUTU, LRN, CSW, AEM and ELMD have been added to the Zacks Rank #1 (Strong Buy) List on September 26, 2025.
ELMDNegative Net Change AEMPositive Net Change LRNPositive Net Change FUTUPositive Net Change CSWNegative Net Change
business-services consumer-discretionary gold industrial-products medical-devices
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI
by Shaun Pruitt
Two medical sector stocks are standing out among the recent additions to the Zacks Rank #1 (Strong Buy) list in Collegium Pharmaceutical (COLL) and Masimo Corporation (MASI).
MASINegative Net Change COLLPositive Net Change ALCNegative Net Change SONVYNegative Net Change
earnings investing medical medical-devices pharmaceuticals
TMDX Partners With Mercedes-Benz to Launch Organ Transport Network
by Zacks Equity Research
TransMedics collaborates with Mercedes-Benz to launch Italy's first organ transport network, expanding its OCS model beyond the United States.
WSTNegative Net Change MEDPNegative Net Change TMDXNegative Net Change NVSTNegative Net Change
medical medical-devices
The Zacks Analyst Blog Highlights Broadcom Oracle, Cisco Systems and United-Guardian
by Zacks Equity Research
Broadcom, Oracle, Cisco Systems, and United-Guardian take center stage in the latest Zacks Analyst Blog with fresh research insights.
CSCOPositive Net Change ORCLNegative Net Change AVGONegative Net Change UGNegative Net Change
computers medical-devices tech-stocks
Masimo Completes Divestment of Consumer Audio Business to HARMAN
by Zacks Equity Research
MASI completes sale of Sound United to HARMAN, sharpening focus on core healthcare, boosting margins, and funding buybacks.
MASINegative Net Change AXGNNegative Net Change INGNNegative Net Change NVSTNegative Net Change
medical medical-devices
Phibro Animal Health Stock Surges 82.1% YTD: What's Fueling It?
by Zacks Equity Research
PAHC rallies 82% YTD with booming vaccines, MFAs and global expansion fueling investor confidence.
BSXPositive Net Change CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change
medical medical-devices
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
by Debanjana Dey
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, ADUS and PNTG are well-poised to gain.
DGXPositive Net Change DVAPositive Net Change ADUSNegative Net Change PNTGPositive Net Change
medical medical-devices
HOLX to Discontinue Fluoroscan InSight FD Soon: Will the Stock Suffer?
by Moumi Mondal
Hologic set to end sales of Fluoroscan InSight FD in 2025 but sees strong momentum from DXA systems and broader business growth.
BDXPositive Net Change HOLXNegative Net Change GEHCNegative Net Change
medical medical-devices
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
by Zacks Equity Research
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
JNJNegative Net Change MDTPositive Net Change SYKPositive Net Change ZBHNegative Net Change
medical medical-devices
Do Options Traders Know Something About Doximity Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to DOCS stock based on the movements in the options market lately.
DOCSNegative Net Change
medical-devices
STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System
by Zacks Equity Research
Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.
STXSPositive Net Change WSTNegative Net Change MEDPNegative Net Change NVSTNegative Net Change
medical medical-devices